Vincerx Pharma, Inc. (VINC) — DEFA14A Filings
All DEFA14A filings from Vincerx Pharma, Inc.. Browse 5 DEFA14A reports with AI-powered summaries and risk analysis.
DEFA14A Filings (5)
-
Vincerx Pharma Files Additional Proxy Materials
— Jul 16, 2025 Risk: low
Vincerx Pharma, Inc. filed a Definitive Additional Materials proxy statement on July 16, 2025. This filing relates to the company's proxy materials, indicating -
Vincerx Pharma Files Proxy Materials
— Jun 18, 2025 Risk: low
Vincerx Pharma, Inc. filed a Definitive Additional Materials proxy statement on June 18, 2025. This filing relates to the company's Schedule 14A information, in -
Vincerx Pharma Files Additional Proxy Materials
— Jun 6, 2025 Risk: low
Vincerx Pharma, Inc. filed a Definitive Additional Materials proxy statement on June 6, 2025. This filing relates to the company's proxy materials previously su -
Vincerx Pharma Proxy Filing
— Jan 29, 2025 Risk: low
Vincerx Pharma, Inc. filed a Definitive Proxy Statement (DEFA14A) on January 29, 2025. This filing is soliciting material under Rule 14a-12, indicating it's rel -
Vincerx Pharma Files Proxy Materials
— Aug 2, 2024 Risk: low
Vincerx Pharma, Inc. filed a Definitive Additional Materials proxy statement on August 2, 2024. This filing relates to the company's proxy materials, indicating
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX